Lista de obras - Katarzyna Durda - Dominio Público Uruguay

11q13 is a susceptibility locus for hormone receptor positive breast cancer

artículo científico publicado en 2012

A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium

artículo científico publicado en 2013

A low selenium level is associated with lung and laryngeal cancers

artículo científico publicado en 2013

A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

artículo científico publicado en 2012

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

artículo científico publicado en 2015

Annual conference on hereditary cancers 2009 szczecin, poland. 10-11 december 2009. Abstracts

article

Arsenic (As) and breast cancer risk.

artículo científico publicado en 2012

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

artículo científico publicado en 2015

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

artículo científico publicado en 2015

Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population

artículo científico publicado en 2018

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium

artículo científico publicado en 2011

CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland

artículo científico publicado en 2010

CHAPTER 22. Selenium and Cancer

artículo científico publicado en 2015

Can selenium levels act as a marker of colorectal cancer risk?

artículo científico publicado en 2013

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Common germline polymorphisms associated with breast cancer-specific survival

artículo científico publicado en 2015

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

artículo científico publicado en 2012

Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

artículo científico publicado en 2012

Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer

artículo científico publicado en 2011

Copper as diagnostic marker of cancers.

artículo científico publicado en 2015

Correction: A Low Selenium Level Is Associated with Lung and Laryngeal Cancers

artículo científico publicado en 2013

Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

artículo científico publicado en 2012

DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

artículo científico publicado en 2014

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium

artículo científico publicado en 2014

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2016

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

artículo científico publicado en 2015

Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

artículo científico publicado en 2014

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.

artículo científico publicado en 2013

Folic acid and breast cancer risk.

artículo científico publicado en 2012

Folic acid and cancer risk in BRCA1 carriers.

artículo científico publicado en 2012

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers

artículo científico publicado en 2013

Genetic predisposition to in situ and invasive lobular carcinoma of the breast

artículo científico publicado en 2014

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

artículo científico publicado en 2014

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

artículo científico publicado en 2014

Genome-wide association analysis identifies three new breast cancer susceptibility loci

artículo científico publicado en 2012

Genome-wide association studies identify four ER negative-specific breast cancer risk loci

artículo científico publicado en 2013

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

artículo científico publicado en 2013

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization

artículo científico publicado en 2015

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

artículo científico publicado en 2014

Identification of novel genetic markers of breast cancer survival

artículo científico publicado en 2015

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

artículo científico publicado en 2016

Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

artículo científico publicado en 2015

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

artículo científico publicado en 2011

Iron as diagnostic marker of cancer.

artículo científico publicado en 2015

Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence

artículo científico publicado en 2019

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

artículo científico publicado en 2013

Magnesium as a diagnostic marker of cancer.

artículo científico publicado en 2015

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015.

artículo científico publicado en 2017

Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016.

artículo científico publicado en 2017

MicroRNA related polymorphisms and breast cancer risk

artículo científico publicado en 2014

Microelements as risk factors for cancer of the lung and larynx.

artículo científico publicado en 2012

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

artículo científico publicado en 2013

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

artículo científico publicado en 2016

Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study

scientific article published on 11 May 2012

Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population

scientific article published on 31 July 2020

Prediction of breast cancer risk based on profiling with common genetic variants

artículo científico publicado en 2015

Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers

artículo científico publicado en 2015

Prospective observation of breast/ovarian cancer risk in BRCA1 carriers depending on serum selenium level optimized with diet

artículo científico publicado en 2012

Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

artículo científico publicado en 2018

Rapid test for detection of high risk of breast cancer

artículo científico publicado en 2012

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

artículo científico publicado en 2014

Selenium (Se) and breast cancer risk

Selenium (Se) and the risk of breast, ovarian and prostate cancers

artículo científico publicado en 2012

Selenium and cancer risk in CHEK2 mutation carriers

Selenium and genotypes as marker of risk in BRCA1 mutation carriers

artículo científico publicado en 2012

Selenium and the risk of cancer in BRCA1 carriers

artículo científico publicado en 2011

Selenium and the risk of cancer of the lung and larynx. A case-control study from a region with low selenium.

artículo científico publicado en 2012

Selenium as a marker of cancer risk and of selection for control examinations in surveillance

artículo científico publicado en 2015

Selenium as diagnostic marker of cancers.

artículo científico publicado en 2015

Selenium as marker for cancer risk and prevention

artículo científico publicado en 2012

Serum 25(OH)D concentration, common variants of the VDR gene and lung cancer occurrence

artículo científico publicado en 2017

Serum folate concentration and the incidence of lung cancer

artículo científico publicado en 2017

The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

scientific article published on 01 November 2019

Vitamins A, E and D and cancer risk in BRCA1 carriers

artículo científico publicado en 2012

Zinc and breast cancer risk

artículo científico publicado en 2012

Zinc as diagnostic marker of cancers.

artículo científico publicado en 2015

Lista de obras de Katarzyna Durda

11q13 is a susceptibility locus for hormone receptor positive breast cancer

A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium

A low selenium level is associated with lung and laryngeal cancers

A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

Annual conference on hereditary cancers 2009 szczecin, poland. 10-11 december 2009. Abstracts

Arsenic (As) and breast cancer risk.

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium

CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland

CHAPTER 22. Selenium and Cancer

Can selenium levels act as a marker of colorectal cancer risk?

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

Common germline polymorphisms associated with breast cancer-specific survival

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer

Copper as diagnostic marker of cancers.

Correction: A Low Selenium Level Is Associated with Lung and Laryngeal Cancers

Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.

Folic acid and breast cancer risk.

Folic acid and cancer risk in BRCA1 carriers.

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers

Genetic predisposition to in situ and invasive lobular carcinoma of the breast

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

Genome-wide association analysis identifies three new breast cancer susceptibility loci

Genome-wide association studies identify four ER negative-specific breast cancer risk loci

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

Identification of novel genetic markers of breast cancer survival

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

Iron as diagnostic marker of cancer.

Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

Magnesium as a diagnostic marker of cancer.

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015.

Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016.

MicroRNA related polymorphisms and breast cancer risk

Microelements as risk factors for cancer of the lung and larynx.

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study

Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population

Prediction of breast cancer risk based on profiling with common genetic variants

Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers

Prospective observation of breast/ovarian cancer risk in BRCA1 carriers depending on serum selenium level optimized with diet

Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

Rapid test for detection of high risk of breast cancer

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

Selenium (Se) and breast cancer risk

Selenium (Se) and the risk of breast, ovarian and prostate cancers

Selenium and cancer risk in CHEK2 mutation carriers

Selenium and genotypes as marker of risk in BRCA1 mutation carriers

Selenium and the risk of cancer in BRCA1 carriers

Selenium and the risk of cancer of the lung and larynx. A case-control study from a region with low selenium.

Selenium as a marker of cancer risk and of selection for control examinations in surveillance

Selenium as diagnostic marker of cancers.

Selenium as marker for cancer risk and prevention

Serum 25(OH)D concentration, common variants of the VDR gene and lung cancer occurrence

Serum folate concentration and the incidence of lung cancer

The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

Vitamins A, E and D and cancer risk in BRCA1 carriers